Beauty Health (NASDAQ:SKIN) Cut to Strong Sell at Zacks Research

Zacks Research lowered shares of Beauty Health (NASDAQ:SKIN) from a hold rating to a strong sell rating in a research note published on Wednesday morning,Zacks.com reports.

SKIN has been the topic of several other reports. Jefferies Financial Group reaffirmed a “hold” rating and set a $1.60 target price on shares of Beauty Health in a report on Wednesday, January 14th. Wall Street Zen cut shares of Beauty Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. TD Cowen raised their target price on shares of Beauty Health from $1.50 to $1.65 and gave the company a “hold” rating in a report on Wednesday. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Beauty Health in a research report on Friday, October 31st. One analyst has rated the stock with a Buy rating, four have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, Beauty Health currently has an average rating of “Reduce” and a consensus target price of $2.40.

Beauty Health Price Performance

Beauty Health stock opened at $1.53 on Wednesday. The company has a market capitalization of $195.08 million, a price-to-earnings ratio of -6.95 and a beta of 1.16. The company has a current ratio of 4.98, a quick ratio of 4.07 and a debt-to-equity ratio of 5.53. Beauty Health has a 12 month low of $0.78 and a 12 month high of $2.69. The stock’s 50 day moving average is $1.45 and its 200-day moving average is $1.69.

Beauty Health (NASDAQ:SKIN) last released its quarterly earnings results on Thursday, November 6th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by ($0.01). Beauty Health had a negative net margin of 3.87% and a negative return on equity of 19.70%. The firm had revenue of $70.66 million during the quarter, compared to the consensus estimate of $68.33 million. Equities research analysts expect that Beauty Health will post -0.25 EPS for the current year.

Institutional Investors Weigh In On Beauty Health

Hedge funds and other institutional investors have recently modified their holdings of the company. Public Employees Retirement System of Ohio acquired a new position in Beauty Health during the 3rd quarter valued at about $26,000. Franklin Resources Inc. bought a new position in shares of Beauty Health in the third quarter valued at approximately $31,000. SG Americas Securities LLC lifted its holdings in shares of Beauty Health by 111.9% in the fourth quarter. SG Americas Securities LLC now owns 24,670 shares of the company’s stock valued at $34,000 after purchasing an additional 13,026 shares in the last quarter. Zacks Investment Management purchased a new position in shares of Beauty Health during the third quarter valued at approximately $35,000. Finally, Ameriprise Financial Inc. bought a new stake in Beauty Health during the third quarter worth $38,000. Institutional investors own 93.26% of the company’s stock.

About Beauty Health

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.